ARTICLE | Company News
Lonza Ltd., Transkaryotic deal
August 9, 2004 7:00 AM UTC
Lonza's Lonza Biologics plc business (Berkshire, U.K.) will manufacture TKTX's Dynepo gene-activated erythropoietin in Europe, where the drug is approved to treat anemia associated with kidney disease...